Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
PRINCETON, N.J., May 23, 2024--Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
The FDA assigns a new target action date of Dec 29, 2024, to Bristol Myers (BMY) BLA for subcutaneous nivolumab (nivolumab and hyaluronidase).